Rikst Nynke Schakel
University Medical Center Groningen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rikst Nynke Schakel.
Laboratory Investigation | 2009
Lu Ping Tan; Miao Wang; Jan-Lukas Robertus; Rikst Nynke Schakel; Johan H. Gibcus; Arjan Diepstra; Geert Harms; Suat-Cheng Peh; Rogier M. Reijmers; Steven T. Pals; Bart-Jan Kroesen; Philip M. Kluin; Sibrand Poppema; Anke van den Berg
MicroRNAs (miRNAs) are an important class of small RNAs that regulate gene expression at the post-transcriptional level. It has become evident that miRNAs are involved in hematopoiesis, and that deregulation of miRNAs may give rise to hematopoietic malignancies. The aim of our study was to establish miRNA profiles of naïve, germinal center (GC) and memory B cells, and validate their expression patterns in normal lymphoid tissues. Quantitative (q) RT-PCR profiling revealed that several miRNAs were elevated in GC B cells, including miR-17-5p, miR-106a and miR-181b. One of the most abundant miRNAs in all three B-cell subsets analyzed was miR-150, with a more than 10-fold lower level in GC B cell as compared with the other two subsets. miRNA in situ hybridization (ISH) in tonsil tissue sections confirmed the findings from the profiling work. Interestingly, gradual decrease of miR-17-5p, miR-106a and miR-181b staining intensity from the dark to the light zone was observed in GC. A strong cytoplasmic staining of miR-150 was observed in a minority of the centroblasts in the dark zone of the GC. Inverse staining pattern of miR-150 against c-Myb and Survivin was observed in tonsil tissue sections, suggesting possible targeting of these genes by miR-150. In line with this, the experimental induction of miR-150 lead to reduced c-Myb, Survivin and Foxp1 expression levels in the Burkitts lymphoma cell line, DG75. In conclusion, miRNA profiles of naïve, GC and memory B cells were established and validated by miRNA ISH. Within the GC cells, a marked difference was observed between the light and the dark zone.
Neoplasia | 2009
Johan H. Gibcus; Lu Ping Tan; Geert Harms; Rikst Nynke Schakel; Debora de Jong; Tjasso Blokzijl; Peter Möller; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Haematologica | 2007
Johan H. Gibcus; Rikst Nynke Schakel; Geertruida Harms; Joost Kluiver; L. P. Tan; S. Popperna; Bart Kroesen; van den Arie Berg
Blood | 2008
Lu Ping Tan; Erwin Seinen; Gerben Duns; Debora Jong; Rikst Nynke Schakel; Geert Harms; Ody C. M. Sibon; Klaas Kok; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Neoplasia | 2018
Johan H. Gibcus; L. P. Tan; Geert Harms; Rikst Nynke Schakel; D. de Jong; Tjasso Blokzijl; Peter Möller; Sibrand Poppema; Bart-Jan Kroesen; A. J. J. van den Berg
Neoplasia | 2018
Johan H. Gibcus; L. P. Tan; Geertruida Harms; Rikst Nynke Schakel; D. de Jong; Tjasso Blokzijl; Peter Möller; Sibrand Poppema; Bart Kroesen; A. J. J. van den Berg
Blood | 2008
Lu Ping Tan; Miao Wang; Jan-Lukas Robertus; Rikst Nynke Schakel; Johan H. Gibcus; Arjan Diepstra; Geert Harms; Suat Cheng Peh; Rogier M. Reijmers; S. T. Pals; Lydia Visser; Philippus Kluin; Sibrand Poppema; Bart Kroesen; van den Anke Berg
Blood | 2008
Johan H. Gibcus; Lu Ping Tan; Rikst Nynke Schakel; Geert Harms; Peter Moeller; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Blood | 2008
Lu Ping Tan; Miao Wang; Jan-Lukas Robertus; Rikst Nynke Schakel; Johan H. Gibcus; Arjan Diepstra; Geert Harms; Suat Cheng Peh; Rogier M. Reijmers; Steven T. Pals; Lydia Visser; Philip M. Kluin; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Blood | 2007
Jan-Lukas Robertus; Miao Wang; Geert Harms; Tjasso Blokzijl; Rikst Nynke Schakel; Daphne de Jong; Rogier M. Reijmers; Steven T. Pals; Stefano Rosati; Ed Schuuring; Philip M. Kluin; Anke van den Berg